Orexo AB

20
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000736415
SEK
22.15
-0.3 (-1.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Orexo AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-403.00
-190.00
-140.00
-170.00
-222.00
-38.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
56.00
-2.00
-53.00
50.00
16.00
52.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
173.00
-32.00
-95.00
-156.00
-229.00
16.00
Cash Flow from Investing Activities
635.00
-5.00
200.00
-234.00
-52.00
-189.00
Cash Flow from Financing Activities
-2.00
-15.00
-70.00
-21.00
250.00
-111.00
Net Cash Inflow / Outflow
789.00
-47.00
38.00
-371.00
-1.00
-311.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-17.00
5.00
3.00
40.00
30.00
-27.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Orexo AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-403
-118.991
-285.00
-238.68%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
56.5
7.488
49.00
654.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
173
-97.33
270.00
277.75%
Cash Flow from Investing Activities
635.9
0
635.00
0.00%
Cash Flow from Financing Activities
-2.3
90.458
-92.00
-102.54%
Net Cash Inflow / Outflow
789.1
-7.804
796.00
10211.48%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-17.5
-0.932
-17.00
-1777.68%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 630.67% vs 65.68% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
173.00
-32.60
630.67%